YS110

· Kissei Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YS110, covering 2020-09-25 to 2020-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]